RCUS
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) has 13 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 13, 2026.
The most active filer is President Jaen Juan C. with 5 filings. Insiders have net sold $3.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Terry J. Rosen
- Employees:601
- HQ:Hayward, CA, US
- IPO:2018-03-14
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.2M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$3.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President | Sale | 48,502 | $1.5M | Jul 13 | SEC ↗ | |
| President | Sale | 20,067 | $574K | Jul 13 | SEC ↗ | |
Jaen Juan C.First filing | President | Sale | 9,236 | $250K | Jun 24 | SEC ↗ |
Jaen Juan C.First filing | President | Sale | 15,764 | $437K | Jun 24 | SEC ↗ |
Jaen Juan C.First filing | President | Sale | 6,431 | $191K | Jun 24 | SEC ↗ |
Azoy AlexanderFirst filing | Chief Accounting Officer | Sale | 2,562 | $66K | Jun 1 | SEC ↗ |
Goeltz II Robert C.First filing | Chief Financial Officer | Sale | 7,763 | $199K | May 12 | SEC ↗ |
Related companies
Arcus Biosciences, Inc. is in the Healthcare sector.